Value8 NV

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0010661864
EUR
6.65
0.05 (0.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Value8 NV stock-summary
stock-summary
Value8 NV
Pharmaceuticals & Biotechnology
Value8 NV, formerly Exendis NV, is a company based in the Netherlands, that invests in and provides services to small and medium-sized companies. The Company focuses on the long term value creation for companies in growing sectors, such as health, leisure, environment, staffing services and Internet. It offers consulting and advising services in various fields, including finance, initial public offering (IPO), investor relations and corporate governance. The Company is active primarily in the Benelux countries and in Western Europe. Value8 operates a number of subsidiaries, including Buhrs International Group BV, VGM Beheer BV, NV Dico International, Ego-Lifestyle Holding NV, Axess Group BV, Amsterdamgold.Com BV, Megapets BV, Discount4Pets.nl, Proud ICT BV (Proud Company) and HulsbosKlatt.
Company Coordinates stock-summary
Company Details
Brediusweg 33 , BUSSUM None : 1401 AB
stock-summary
Tel: 31 35 7111387
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Peter van der Lugt
Chairman of the Supervisory Board
Dr. J. Pontier
Member of the Supervisory Board
Prof. Dr. Jaap van Duijn
Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 62 Million ()

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.99%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

4.00%

stock-summary
Price to Book

0.57